CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Trump is guilty of mortgage ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Utilizing the gene-editing technology CRISPR, researchers have found a way to combat chemoresistance in lung cancer cells, restoring hope for patients. Shannon Horning/ SciTech Editor For patients ...

CRISPR screens often mislead cancer research because bacterial Cas9 components trigger immune reactions in mice. ETH Zurich researchers developed a “stealth” CRISPR approach that removes immunogenic ...